Sequential azacitidine and carboplatin induces immune activation in platinum-resistant high-grade serous ovarian cancer cell lines and primes for checkpoint inhibitor immunotherapy

Peer Review reports

Original Submission
3 Aug 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
28 Sep 2021	Reviewed	Reviewer Report
18 Nov 2021	Reviewed	Reviewer Report
23 Nov 2021	Author responded	Author comments - Michelle W.Y. Wong-Brown
Resubmission - Version 3
23 Nov 2021	Submitted	Manuscript version 3
2 Dec 2021	Author responded	Author comments - Michelle W.Y. Wong-Brown
Resubmission - Version 4
2 Dec 2021	Submitted	Manuscript version 4
Publishing
20 Dec 2021	Editorially accepted
24 Jan 2022	Article published	10.1186/s12885-022-09197-w

Back to article page